Management of allergy to heparins in postoperative care: Subcutaneous allergy and intravenous tolerance

Dermatology Online Journal

Volumn 14, Issue 9, 2008, Pages

  Seitz, Cornelia S ^a   Brocker, Eva B ^a   Trautmann, Axel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; DANAPAROID; ENOXAPARIN; GLUCOCORTICOID; HEPARIN; ANTICOAGULANT AGENT; CHONDROITIN SULFATE; DERMATAN SULFATE; HEPARAN SULFATE;

AGED; ANTICOAGULATION; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CROSS REACTION; DEEP VEIN THROMBOSIS; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; ECZEMA; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INJECTION SITE DERMATITIS; INJECTION SITE REACTION; LYMPHOCYTIC INFILTRATION; ORTHOPEDIC SURGERY; PAPULE; POSTOPERATIVE CARE; PRURITUS; SKIN ALLERGY; THROMBOSIS PREVENTION; VESICULAR RASH; CHEMICALLY INDUCED DISORDER; IMMOBILIZATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; POSTOPERATIVE COMPLICATION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOPHILIA; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; CHONDROITIN SULFATES; DERMATAN SULFATE; DERMATITIS, ALLERGIC CONTACT; ECZEMA; FEMALE; HEPARIN; HEPARITIN SULFATE; HUMANS; IMMOBILIZATION; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 54549114257     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Klein GF, Kofler H, Wolf H, Fritsch PO. Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy. J Am Acad Dermatol. 1989 Oct;21 (4 Pt 1):703-7. PubMed
2. Estrada Rodriguez JL, Gozalo Reques F, Ortiz de Urbina J, Matilla B, Rodriguez Prieto MA, Gonzalez Moran NA. Generalized eczema induced by nadroparin. J Investig Allergol Clin Immunol. 2003;13(1):69-70. PubMed
3. Kim KH, Lynfield Y. Enoxaparin-induced generalized exanthem. Cutis. 2003 Jul;72(1):57-60. PubMed
4. Grassegger A, Fritsch P, Reider N. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study. Dermatol Surg. 2001 Jan;27(1):47-52. PubMed
5. Boehncke WH, Weber L, Gall H. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids. Contact Dermatitis. 1996 Aug;35(2):73-5. PubMed
6. Trautmann A, Brocker EB, Klein CE. Intravenous challenge with heparins in patients with delayed-type skin reactions after subcutaneous administration of the drug. Contact Dermatitis. 1998 Jul;39(1):43-4. PubMed
7. Gaigl Z, Pfeuffer P, Raith P, Brocker EB, Trautmann A. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study. Br J Haematol. 2005 Feb;128(3):389-92. PubMed
8. Kroon C, de Boer A, Kroon JM, Schoenmaker HC, van den Meer FJ, Cohen AF. Influence of skinfold thickness on heparin absorption. Lancet. 1991 Apr 20;337(8747):945-6. PubMed
9. Warkentin TE, Roberts RS, Hirsh J, Kelton JG. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study. Chest. 2005 May;127(5):1857-61. PubMed
10. Kam PC, Kaur N, Thong CL. Direct thrombin inhibitors: pharmacology and clinical relevance. Anaesthesia. 2005 Jun;60(6):565-74. PubMed
11. Hyers TM. Management of venous thromboembolism: past, present, and future. Arch Intern Med. 2003 Apr 14;163(7):759-68. PubMed